ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes Post author:Cleo Sciscioli Post published:June 5, 2023 Post category:Newsroom Erytech announces that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the merger with Pherecydes at the Annual General Meeting on June 23. You Might Also Like ERYTECH appoints new independent board member March 26, 2015 ERYTECH Provides Update on the Announced Combination with PHERECYDES May 16, 2023 ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016